Rosacea Treatment Depends on Which Rosacea You Have
SaveThe 2017 rosacea classification moved away from rigid subtypes toward phenotypes — the features a person really has. That shift is practical: it tells you the treatment follows the feature. This guide walks the four familiar pictures of rosacea and the therapy matched to each, from vessel-narrowing creams and lasers to anti-inflammatory topicals, oral options, and surgery for thickened skin.
Last updated: July 2026
Why rosacea treatment depends on the type
Rosacea is not one condition with one cure, and that is the key to treating it. The National Rosacea Society's 2017 update reframed rosacea around phenotypes — the specific features a person actually has — rather than rigid subtypes, because most people show a mix that shifts over time 1Ref 1National Rosacea Society Expert Committee (Gallo RL, Granstein RD, Kang S, et al.) (2018).Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.The phenotype-based classification of rosacea: persistent centrofacial redness and phymatous change as individually diagnostic, and flushing, telangiectasia, papulopustules, and ocular signs as supporting features.. Persistent redness across the central face and skin thickening are each diagnostic on their own; flushing, visible vessels, bumps and pustules, and eye symptoms are supporting features 1Ref 1National Rosacea Society Expert Committee (Gallo RL, Granstein RD, Kang S, et al.) (2018).Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.The phenotype-based classification of rosacea: persistent centrofacial redness and phymatous change as individually diagnostic, and flushing, telangiectasia, papulopustules, and ocular signs as supporting features..
What this means in practice: the treatment is aimed at the features you have, not at a label. Someone whose main problem is background redness needs a different plan from someone breaking out in inflammatory bumps, even though both have rosacea. Many people need to treat two or three features at once, and the plan changes as the disease does.
The features tend to cluster into four familiar pictures — persistent redness and flushing, bumps and pustules, thickening skin, and eye involvement. The sections below take each in turn. A single person may recognize themselves in more than one.
Persistent redness and flushing
Persistent facial redness and flushing are the most common face of rosacea, and the hardest to erase, because much of the redness comes from blood vessels rather than inflammation you can simply calm. The 2019 management update lists topical brimonidine and oxymetazoline, which narrow the small vessels to reduce redness for several hours, and light-based treatments — laser and intense pulsed light — for the fine visible vessels that topicals cannot reach 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma..
Two different problems hide inside redness. Telangiectasias are the thread-like vessels you can see; those respond to laser or light, not cream. Background flush and blush respond partly to the vessel-narrowing topicals and, above all, to identifying and avoiding personal triggers. Sun, heat, alcohol, spicy food, and stress are the classic ones, though the list is individual.
The honest caveat with the redness-reducing topicals is rebound: some people find the flush returns, occasionally worse, as the medication wears off. That does not happen to everyone, and it is worth discussing before starting, because a daily topical for redness is a long-term commitment, not a one-time fix. For the fixed redness that treatment cannot fully erase, green-tinted color-correcting makeup neutralizes it cosmetically, and many people pair that with the medical options rather than choosing between them.
Bumps and pustules
The bumps-and-pustules form of rosacea — small red papules and pus-tipped spots across the cheeks, nose, chin, and forehead — is the most treatable, because it responds to anti-inflammatory therapy. The 2019 update lists topical metronidazole, azelaic acid, and ivermectin as mainstays, with a low, anti-inflammatory dose of oral doxycycline (subantimicrobial dosing) for more stubborn or widespread bumps 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma..
The topicals do different jobs. Metronidazole and azelaic acid reduce inflammation broadly; ivermectin adds an effect on the Demodex skin mites thought to help drive this form. Many dermatologists combine a topical with the oral option for a few months to gain control, then step down to a topical alone for maintenance 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. Timelines help set expectations: the bumps typically take several weeks to respond, so judging a treatment too early — before it has had a fair run — is a common reason people conclude wrongly that it has failed.
This is the form most likely to clear well with treatment. The bumps of rosacea can look and feel like acne, which is exactly why the next question matters: the two are treated very differently, and reaching for acne products can make rosacea worse.
How rosacea treatment differs from acne
Rosacea and acne can look alike — both bring red bumps to the face — but they are different diseases, and treating rosacea like acne often backfires. Acne is driven by clogged, oily pores and is treated, per the AAD acne guideline, with agents like benzoyl peroxide and topical retinoids that exfoliate and unclog the pores 3Ref 3Reynolds RV, Yeung H, Cheng CE, et al. (2024).Guidelines of care for the management of acne vulgaris.That acne is treated with agents such as benzoyl peroxide and topical retinoids that unclog pores — the contrast that explains why acne therapy can aggravate rosacea-prone skin.. Those same agents are frequently too harsh for rosacea-prone skin and can inflame the redness further.
Rosacea, by contrast, is treated with the gentler anti-inflammatory topicals above — metronidazole, azelaic acid, ivermectin — chosen to quiet inflammation without stripping an already reactive barrier 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. The tell is often the background. Rosacea usually sits on a bed of persistent central-face redness and flushing and lacks the blackheads and whiteheads that mark acne.
Getting this distinction right is why a diagnosis matters before a routine. Rosacea vs acne is one of the more common mix-ups in facial skin, and the treatment that helps one can aggravate the other. When bumps sit on flushing that never fully settles, rosacea is the more likely story. Because the two can also coexist — some people genuinely have both — a clinician may treat them in parallel with a carefully chosen combination, which is another reason a proper diagnosis beats guessing at the pharmacy.
Thickening skin and rhinophyma
Phymatous rosacea is the thickening form — the skin, most often on the nose, slowly coarsens and enlarges as oil glands and connective tissue overgrow. It is more common in men and, importantly, it is the one form where creams have the least to offer once thickening is established. Rhinophyma, the enlarged, bumpy nose, is the best-known example.
The 2019 update splits the approach by timing. Early, inflammatory phymatous change may be slowed with oral isotretinoin, which shrinks the oil glands driving the growth 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. Established thickening, however, is a structural change, and it is addressed physically — with laser resurfacing, electrosurgery, or surgical reshaping to remove the excess tissue and recontour the skin 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma..
This is where waiting has a cost. Because established phymatous rosacea does not reverse with medication, catching and treating the inflammatory phase early is the best chance to limit how far the thickening goes. Anyone noticing the skin of the nose or cheeks coarsening is worth having evaluated before it advances. For established rhinophyma, the physical options can meaningfully restore the nose's shape, so even long-standing thickening is treatable — it simply calls for a procedure rather than a cream 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma..
When rosacea reaches the eyes
Ocular rosacea affects the eyes and eyelids, and it is easy to miss because it can arrive without much facial redness. The signs are burning, grittiness, dryness, redness of the lid margins, styes, and a feeling of something in the eye; the 2017 classification lists these ocular features as part of the rosacea picture 1Ref 1National Rosacea Society Expert Committee (Gallo RL, Granstein RD, Kang S, et al.) (2018).Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.The phenotype-based classification of rosacea: persistent centrofacial redness and phymatous change as individually diagnostic, and flushing, telangiectasia, papulopustules, and ocular signs as supporting features.. Left unaddressed, severe cases can threaten the cornea, so it is not a cosmetic footnote.
Treatment starts with daily lid care — warm compresses and gentle cleansing of the lid margins to unblock the oil glands along the lash line. For more than mild cases, the 2019 update supports an anti-inflammatory dose of oral doxycycline 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. Persistent or painful eye symptoms warrant referral to an ophthalmologist, because the eye assessment rosacea sometimes needs is beyond what a skin exam can give.
One practical point: the facial and ocular forms do not always track together. Well-controlled facial rosacea does not guarantee quiet eyes, so eye symptoms are worth mentioning at every visit even when the skin looks fine. Simple measures like artificial tears for dryness and consistent lid hygiene often do more day to day than any single prescription, and keeping them up during quiet spells helps head off the next flare.
When creams aren't enough, and keeping rosacea quiet
When first-line topicals and the usual oral options do not control rosacea, treatment escalates — and rosacea escalation is a normal step, not a dead end. When creams and antibiotics fall short, isotretinoin for rosacea becomes an option a dermatologist may raise for severe, resistant disease 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. When rosacea outgrows the creams, that is the point to return to a dermatologist rather than layering on more products.
Maintenance is the other half of control. Rosacea is chronic and relapsing, so most plans that reach clearance then shift to an ongoing low-effort routine — a maintenance topical, gentle non-stripping skin care, daily sun protection, and steady trigger avoidance — to hold the gains 2Ref 2National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.. The aim is a stable baseline you can keep, not a one-time clearing that fades.
Across every form, three things carry more weight than any single product: a correct read of which features you actually have, sun protection, and knowing your own triggers. Get those right, and the specific medication becomes a choice you and a dermatologist can fine-tune over time. Rosacea rewards patience and consistency more than intensity: steady, gentle care applied over months does more than aggressive bursts, and the people who do best are usually the ones who found a simple routine they could sustain.
Common questions
Related
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When rosacea needs prompt care
- —Eye pain, light sensitivity, blurred vision, or a red, painful eye — ocular rosacea can threaten the cornea and needs an eye exam
- —Rapid thickening or swelling of the skin on the nose or face
- —A rosacea flare that suddenly turns hot, swollen, and spreading, especially with fever — possible skin infection
- —Facial redness with widespread rash, blistering, or peeling after starting a new medication — this may not be rosacea
Sudden eye pain with vision change needs same-day medical care — seek urgent eye care or go to an emergency room if your vision is affected.
This article explains how the different forms of rosacea are generally treated and cannot diagnose your skin. A clinician who can examine you decides which features you have and which treatment, including any medication, fits.
References
- 1.National Rosacea Society Expert Committee (Gallo RL, Granstein RD, Kang S, et al.) (2018). Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology. PMID 29089180 ✓The phenotype-based classification of rosacea: persistent centrofacial redness and phymatous change as individually diagnostic, and flushing, telangiectasia, papulopustules, and ocular signs as supporting features.
- 2.National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020). Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2020.01.077Phenotype-directed rosacea management: topical brimonidine, oxymetazoline, metronidazole, azelaic acid, and ivermectin; subantimicrobial-dose oral doxycycline and isotretinoin; and light/laser for telangiectasia and phyma.
- 3.Reynolds RV, Yeung H, Cheng CE, et al. (2024). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. PMID 38300170 ✓That acne is treated with agents such as benzoyl peroxide and topical retinoids that unclog pores — the contrast that explains why acne therapy can aggravate rosacea-prone skin.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy